Antigenicity of a recombinant Ro (SS-A) fusion protein

Arthritis Rheum. 1990 Jan;33(1):102-6. doi: 10.1002/art.1780330114.

Abstract

The antigenicity of the 60-kd human Ro (SS-A) synthesized in vitro from its complementary DNA as a beta-galactosidase fusion protein (beta-gal-Ro) was evaluated by Western blotting. In this analysis, almost all the anti-Ro (SS-A)-positive sera that bound beta-gal-Ro also bound affinity-purified 60-kd human Ro (SS-A) (P less than 0.005). Three of the 27 anti-Ro (SS-A) precipitin-positive sera, however, did not show reactivity on Western blot analysis, which suggests that in some sera, antigenicity to Ro (SS-A) is destroyed by denaturation. Of the 22 sera that were reactive with beta-gal-Ro, 2 were not reactive with affinity-purified human Ro (SS-A). Two serum samples that did not react with beta-gal-Ro were also reactive with affinity-purified human Ro (SS-A). Nevertheless, except for a small percentage of Ro (SS-A) precipitin-positive sera, the frequency of antibody binding to the fusion protein was similar to the frequency of binding to the purified antigen in Western blots. Recombinant Ro (SS-A) antigen may therefore be valuable in the serologic evaluation of anti-Ro (SS-A) autoantibodies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Autoantigens / immunology*
  • Blotting, Western
  • Epitopes
  • Humans
  • Immune Sera / immunology
  • Molecular Weight
  • RNA, Small Cytoplasmic*
  • Recombinant Fusion Proteins / analysis
  • Recombinant Fusion Proteins / immunology*
  • Rheumatic Diseases / immunology
  • Ribonucleoproteins*
  • beta-Galactosidase / analysis

Substances

  • Autoantigens
  • Epitopes
  • Immune Sera
  • RNA, Small Cytoplasmic
  • RO60 protein, human
  • Recombinant Fusion Proteins
  • Ribonucleoproteins
  • SS-A antigen
  • beta-Galactosidase